Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00762333 · ClinicalTrials.gov registry record

Circulating Markers for Ischemic Heart Disease

A clinical trial of Myocardial Infarction and Congestive Heart Failure, sponsored by UConn Health.

Recruiting
Registry status
550
Enrollment target
1
Study location

NCT00762333 is a study of Myocardial Infarction and Congestive Heart Failure that is actively recruiting participants, run by UConn Health. The registered enrollment target is 550 participants, below the 4,673-participant average among 64 other Myocardial Infarction trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00762333, a study of Myocardial Infarction and Congestive Heart Failure, is actively recruiting participants, sponsored by UConn Health.

RECRUITING
Registry status
550 participants
Enrollment target
1
Study location

Study Summary

The purpose of this research is to determine if two proteins in the blood are increased during acute myocardial infarction and whether their levels are higher in those who develop heart failure than those who do not. These two proteins are produced and potentially released when the heart muscle is damaged. They may then be released into the blood and be detected by standard method in the research laboratory. At this time, detection of an increase in these proteins in the blood is not known to be associated with any disease or myocardial infarction.

Study Locations (1)

Connecticut

  • University of Connecticut Health Center - Farmington

Trial Details

FieldValue
Enrollment Target 550 participants
Start Date 2007-06
Est. Completion 2027-03

Sponsor

UConn Health

178 total trials

What the Registry Record Tells You About NCT00762333

The ClinicalTrials.gov registry entry for NCT00762333 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 550 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,673-participant average among 64 other Myocardial Infarction trials with a reported enrollment target (88% lower). The listed sponsor is UConn Health, which has 178 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Myocardial Infarction appearing as the primary indexed condition, and to 0 interventions.

NCT00762333 reports 1 study location spanning 1 distinct geographic area - top geographies include Connecticut.

Frequently Asked Questions

What is clinical trial NCT00762333 about?

NCT00762333 is a clinical study titled "Circulating Markers for Ischemic Heart Disease". The purpose of this research is to determine if two proteins in the blood are increased during acute myocardial infarction and whether their levels are higher in those who develop heart failure than those who do not. These two proteins are produced and potentially released when the heart muscle is d...

What is the current status of trial NCT00762333?

This trial is currently recruiting. The enrollment target is 550 participants. The study started on 2007-06. Estimated completion is 2027-03.

What conditions does trial NCT00762333 study?

This clinical trial studies the following conditions: Myocardial Infarction, Congestive Heart Failure, Ischemia.

Who is sponsoring clinical trial NCT00762333?

This trial is sponsored by UConn Health, which has 178 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00762333 being conducted?

This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Myocardial Infarction

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.